Dermal matrix scaffold engineered with adult mesenchymal stem cells and platelet-rich plasma as a potential tool for tissue repair and regeneration

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 2, 2012, Pages 125-134

  Formigli, Lucia ^a   Benvenuti, Susanna ^a   Mercatelli, Raffaella ^b   Quercioli, Franco ^b   Tani, Alessia ^a   Mirabella, Carlo ^c   Dama, Aida ^a   Saccardi, Riccardo ^c   Mazzanti, Benedetta ^c   Cellai, Ilaria ^a   Zecchi Orlandini, Sandra ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CNR   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Biomaterials; Growth factors; Mesenchymal stem cells; Multiphoton microscopy; Platelet rich plasma; Regenerative medicine

Indexed keywords

CELL ADHESION; CELL ENGINEERING; CELL PROLIFERATION; FLUORESCENCE IMAGING; GENE EXPRESSION; PLATELETS; REGENERATIVE MEDICINE; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE; TISSUE REGENERATION;

DERMAL MATRIX; GROWTH FACTOR; HUMAN BONE MARROW DERIVED MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; MULTIPHOTON MICROSCOPY; PLATELET RICH PLASMA; POTENTIAL TOOL; REGENERATIVE MEDICINE; SKIN REGENERATION; TISSUE REPAIR;

CELL CULTURE;

GROWTH FACTOR;

ADULT; ARTICLE; BIOENGINEERING; BONE MARROW; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE LIFETIME IMAGING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; MESENCHYMAL STEM CELL; MICROSCOPY; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR;

EID: 84856255169     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.405     Document Type: Article

References (44)

1. Aiba-Kojima E, Tsuno NH, Inoue K, et al. 2007; Characterization of wound drainage fluids as a source of soluble factors associated with wound healing: comparison with platelet-rich plasma and potential use in cell culture. Wound Repair Regen 15: 511-520.
2. Anitua E, Aguirre JJ, Algorta J, et al. 2008; Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 84: 415-421.
3. Asari S, Itakura S, Ferreri K, et al. 2009; Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol 37: 604-615.
4. Badillo AT, Peranteau WH, Heaton TE, et al. 2008; Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease. Br J Haematol 141: 224-234.
5. Bailey AS, Willenbring H, Jiang S, et al. 2006; Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA 29: 13156-13161.
6. Benvenuti S, Saccardi R, Luciani P, et al. 2006; Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1. Exp Cell Res 312: 2592-2604.
7. Bianco P, Robey PG. 2001; Stem cell in tissue engineering. Nature 414: 118-121.
8. Campitiello E, Della Corte A, Fattopace A, et al. 2005; The use of artificial dermis in the treatment of chronic and acute wounds: regeneration of dermis and wound healing. Acta Biomed 76: 69-71.
9. Carnio S, Serena E, Rossi CA, et al. 2010; Three-dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic muscle. J Tissue Eng Regen Med (in press).
10. Chen WH, Liu HY, Lo WC, et al. 2009; Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma. Biomaterials 30: 5523-5533.
11. Corcione A, Benvenuto F, Ferretti E, et al. 2006; Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372.
12. Crovetti G, Martinelli G, Issi M, et al. 2004; Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 30: 145-151.
13. Da Silva Meirelles L, Caplan AI, Nardi NB. 2008; In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26: 2287-2299.
14. Deans RJ, Moseley AB. 2000; Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28: 875-884.
15. Formigli L, Francini F, Nistri S, et al. 2009; Skeletal myoblasts overexpressing relaxin improve differentiation and communication of primary murine cardiomyocyte cell cultures. J Mol Cell Cardiol 47: 335-345.
16. Hamdi H, Furuta A, Bellamy V, et al. 2009; Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 87: 1196-1203.
17. Kashyap V, Rezende NC, Scotland KB, et al. 2009; Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the Nanog, OCT4 and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 18: 1093-1108.
18. Kasten P, Vogel J, Geiger F, et al. 2008; The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29: 3983-3992.
19. Kuhn NZ, Tuan RS. 2010; Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 222: 268-277.
20. Machens HG, Berger AC, Mailaender P. 2000; Bioartificial skin. Cells Tissues Organs 167: 88-94.
21. Mazzanti B, Aldinucci A, Biagioli T, et al. 2008; Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment. J Neuroimmunol 199: 142-150.
22. Melendez MM, Martinez RR, Dagum AB, et al. 2008; Porcine wound healing in full-thickness skin defects using Integra with and without fibrin glue with keratinocytes. Can J Plast Surg 16: 147-152.
23. Mercatelli R, Quercioli F, Barsanti L, et al. 2009; Intramolecular photo-switching and intermolecular energy transfer as primary photoevents in photoreceptive processes: the case of Euglena gracilis. Biochem Biophys Res Commun 385: 176-180.
24. Moiemen NS, Vlachou E, Staiano JJ, et al. 2006; Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practice. Plast Reconstr Surg 117: 160-174S.
25. Nauta AJ, Fibbe WE. 2007; Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
26. Nelson TJ, Behfar A, Yamada S, et al. 2009; Stem cell platforms for regenerative medicine. Clin Transl Sci 2: 222-227.
27. Nguyen DQ, Dickson WA. 2006; A review of the use of a dermal skin substitute in burns care. J Wound Care 15: 373-376.
28. Nincheri P, Luciani P, Squecco R, et al. 2009; Sphingosine 1-phosphate induces differentiation of adipose tissue-derived mesenchymal stem cells towards smooth muscle cells. Cell Mol Life Sci 66: 1741-1754.
29. Ophof R, Maltha JC, Kuijpers-Jagtman AM, et al. 2007; Evaluation of a collagen-glycosaminoglycan dermal substitute in the dog palate. Tissue Eng 13: 2689-2698.
30. Pietramaggiori G, Scherer SS, Mathews JC, et al. 2008; Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen 16: 218-225.
31. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
32. Popescu LM, Gherghiceanu M, Manole CG, et al. 2009; Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches. J Cell Mol Med 13: 866-886.
33. Prins HJ, Rozemuller H, Vonk-Griffioen S, et al. 2009; Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substrate for fetal bovine serum. Tissue Eng A 15: 3741-3752.
34. Rosenthal N. 2003; Prometheus's vulture and the stem-cell promise. N Engl J Med 349: 267-274.
35. Salem HK, Thiemermann C. 2010; Mesenchymal stromal cells-current understanding and clinical status. Stem Cells 28: 585-596.
36. Satija NK, Gurudutta GU, Sharma S, et al. 2007; Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cell Dev 16: 7-23.
37. Shaterian A, Borboa A, Sawada R, et al. 2009; Real-time analysis of the kinetics of angiogenesis and vascular permeability in an animal model of wound healing. Burns 35: 811-817.
38. Stock UA, Vacanti JP. 2001; Tissue engineering: current state and prospects. Annu Rev Med 52: 443-451.
39. Tonti GA, Mannello F. 2008; From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera. Int J Dev Biol 52: 1023-1032.
40. Traphagen S, Yelick PC. 2009; Reclaiming a natural beauty: whole-organ engineering with natural extracellular materials. Regen Med 4: 747-758.
41. Van Den Dolder J, Mooren R, Vloon AP, et al. 2006; Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 12: 3067-3073.
42. Weibrich G, Gnoth SH, Otto M, et al. 2002; Growth stimulation of human osteoblast-like cells by thrombocyte concentrates in vitro. Mund Kiefer Gesichtschir 6: 168-174.
43. Wilcke I, Lohmeyer JA, Liu S, et al. 2007; VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. Langenbecks Arch Surg 392: 305-314.
44. Zuk PA, Zhu M, Ashjian P, et al. 2002; Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.